Search
-
Andrew Dunn: Page 156
https://staffblogs.le.ac.uk/socscilibrarians/author/andrew_dunn/page/156/
Academic Librarian.
-
Social Sciences and Humanities Librarians’ Blog: Academic and staff blogs from the University of Lei
https://staffblogs.le.ac.uk/socscilibrarians/page/39/
Academic and staff blogs from the University of Leicester
-
Social Sciences and Humanities Librarians’ Blog: Academic and staff blogs from the University of Lei
https://staffblogs.le.ac.uk/socscilibrarians/page/157/
Academic and staff blogs from the University of Leicester
-
Andrew Dunn: Page 39
https://staffblogs.le.ac.uk/socscilibrarians/author/andrew_dunn/page/39/
Academic Librarian.
-
Andrew Dunn: Page 165
https://staffblogs.le.ac.uk/socscilibrarians/author/andrew_dunn/page/165/
Academic Librarian.
-
Social Sciences and Humanities Librarians’ Blog: Academic and staff blogs from the University of Lei
https://staffblogs.le.ac.uk/socscilibrarians/page/166/
Academic and staff blogs from the University of Leicester
-
Bacteriophages
https://le.ac.uk/lemid/strategic-areas/bacteriophages
Bacteriophage (phage) are small viruses that infect bacteria. They are either lytic: they undergo a productive infection within a bacterial cell causing death or they are lysogenic. The study of phage can be utilised for the treatment of antibiotic resistant infection.
-
In my prison notebook
https://staffblogs.le.ac.uk/carchipelago/2016/08/29/in-my-prison-notebook/
Posted by Carrie Crockett in Carceral Archipelago on August 29, 2016 Last year I came across a rare archival find: multiple editions of a 19th century prison newspaper covertly produced by Russian inmates between 1890 and 1905.
-
Equipment
https://le.ac.uk/cbs/facilities/emf/equipment
Browse the equipment available for use in the Electron Microscopy Facility at the University of Leicester.
-
Study reviews new once-weekly Type 2 diabetes drugs
https://le.ac.uk/news/2015/december/study-reviews-new-once-weekly-type-2-diabetes-drugs
Once-weekly glucagon-like peptide-1 receptor agonists (GLP-1RAs) differ in their efficacy and safety profiles, according to new research by researchers from the Leicester Diabetes Centre. Compared to other once-weekly GLP-1RAs which are licensed and available, dulaglutide 1.